ENTRY       D08990                      Drug
NAME        Romiplostim (USAN/INN);
            Romiplostim (genetical recombination) (JAN);
            Nplate (TN);
            Romiplate (TN)
PRODUCT     NPLATE (Amgen)
FORMULA     C1317H2043N361O395S9
EXACT_MASS  29523.8362
MOL_WEIGHT  29542.08
REMARK      Therapeutic category: 3999
            ATC code: B02BX04
            Product: D08990<JP/US>
EFFICACY    Antithrombocytopenia, Thrombopoietin receptor agonist
  DISEASE   Chronic immune thrombocytopenia [DS:H01240]
COMMENT     Fusion protein (Thrombopoietin-binding peptide fused to Fc of human IgG1)
            Treatment of immune thrombocytopenic purpura (ITP)
TARGET      MPL (TPOR, CD110) [HSA:4352] [KO:K05082]
  PATHWAY   hsa04060(4352)  Cytokine-cytokine receptor interaction
            hsa04630(4352)  JAK-STAT signaling pathway
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B02 ANTIHEMORRHAGICS
               B02B VITAMIN K AND OTHER HEMOSTATICS
                B02BX Other systemic hemostatics
                 B02BX04 Romiplostim
                  D08990  Romiplostim (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Products and Modifiers
              Blood Products and Modifiers, Other
               Blood Products and Modifiers, Micellaneous
                Romiplostim
                 D08990  Romiplostim (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D08990  Romiplostim (USAN/INN); Romiplostim (genetical recombination) (JAN)
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               CSF and other factor receptors
                MPL (TPOR, CD110)
                 D08990  Romiplostim (USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D08990
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D08990
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D08990
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D08990
DBLINKS     CAS: 267639-76-9
            PubChem: 96025673
///
